# Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism

> **NCT00110708** · PHASE2 · UNKNOWN · sponsor: **PediaMed Pharmaceuticals** · enrollment: 120 (—)

## Conditions studied

- Autism
- Autistic Disorder
- Child Development Disorders, Pervasive
- Gastrointestinal Diseases
- Signs and Symptoms, Digestive

## Interventions

- **DRUG:** Oralgam (human immunoglobulin)

## Key facts

- **NCT ID:** NCT00110708
- **Lead sponsor:** PediaMed Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 120 (—)
- **Last updated:** 2006-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110708, "Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00110708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*